Consolidation in the Spinal Implant Market
This is the second big deal in the spinal implant market in the last three months. With its acquisition of Acromed, DePuy establishes itself as a strong Number 2 in what company officials believe is the fastest growing market in orthopedics today. Moreover, it did so at a fraction of the price Sulzer paid to get SpineTech just a couple of years earlier. While industry officials shake their heads at Sulzer's largesse, company officials are betting that SpineTech's cage technology represents a breakthrough product in spinal implants.
You may also be interested in...
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.